Middle East
A. Menarini Gets European Rights to Nucleix Bladder Cancer Test
The CE-marked and FDA-cleared test analyzes disease-specific changes in 15 DNA methylation markers in urine using qPCR.
The company is piloting an air-gapped version of its PandaOmics platform, while making the latest version of its PreciousGPT software open to all.
Centogene Delisted From Nasdaq
The German rare disease company expects its common stock to begin trading on the OTC Markets Group platform on Aug. 8 under the ticker symbol CNTGF.
Pangea Biomed, Hadassah University, Ultima Genomics Team up to Improve Tumor Treatment Predictions
The companies will partner with researchers at Hadassah to apply genomic, transcriptomic, and artificial intelligence technologies to treatment predictions for cancer patients.
Clinical Trial Exome Sequencing Shows No Link Between Clonal Hematopoiesis, Repeat Coronary Events
Researchers saw a relationship between incident coronary events and an age-related form of blood stem cell expansion, without ties to subsequent events.